These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22797490)

  • 21. Pharmacoeconomic analysis of osteoporosis treatment with risedronate.
    Brecht JG; Kruse HP; Felsenberg D; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2003; 23(4):93-105. PubMed ID: 15224498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.
    Ni W; Jiang Y
    Osteoporos Int; 2017 Feb; 28(2):529-538. PubMed ID: 27581955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The current economic burden of illness of osteoporosis in Canada.
    Hopkins RB; Burke N; Von Keyserlingk C; Leslie WD; Morin SN; Adachi JD; Papaioannou A; Bessette L; Brown JP; Pericleous L; Tarride J
    Osteoporos Int; 2016 Oct; 27(10):3023-32. PubMed ID: 27166680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effective osteoporosis treatment thresholds in Greece.
    Makras P; Athanasakis K; Boubouchairopoulou N; Rizou S; Anastasilakis AD; Kyriopoulos J; Lyritis GP
    Osteoporos Int; 2015 Jul; 26(7):1949-57. PubMed ID: 25740208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted?
    Gajic-Veljanoski O; Bayoumi AM; Tomlinson G; Khan K; Cheung AM
    Osteoporos Int; 2012 Nov; 23(11):2681-92. PubMed ID: 22398856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.
    Burge R; Dawson-Hughes B; Solomon DH; Wong JB; King A; Tosteson A
    J Bone Miner Res; 2007 Mar; 22(3):465-75. PubMed ID: 17144789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Projecting Long-term Health and Economic Burden of COPD in the United States.
    Zafari Z; Li S; Eakin MN; Bellanger M; Reed RM
    Chest; 2021 Apr; 159(4):1400-1410. PubMed ID: 33011203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
    Su Y; Lai FTT; Yip BHK; Leung JCS; Kwok TCY
    Osteoporos Int; 2018 Aug; 29(8):1793-1805. PubMed ID: 29774400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of hip fracture on hospital care costs: a population-based study.
    Leal J; Gray AM; Prieto-Alhambra D; Arden NK; Cooper C; Javaid MK; Judge A;
    Osteoporos Int; 2016 Feb; 27(2):549-58. PubMed ID: 26286626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis.
    Hopkins RB; Tarride JE; Leslie WD; Metge C; Lix LM; Morin S; Finlayson G; Azimaee M; Pullenayegum E; Goeree R; Adachi JD; Papaioannou A; Thabane L
    Osteoporos Int; 2013 Feb; 24(2):581-93. PubMed ID: 22572964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reassessment of osteoporosis-related femoral fractures and economic burden in Saudi Arabia.
    Sadat-Ali M; Al-Dakheel DA; Azam MQ; Al-Bluwi MT; Al-Farhan MF; AlAmer HA; Al-Meer Z; Al-Mohimeed A; Tabash IK; Karry MO; Rassasy YM; Baragaba MA; Amer AS; AlJawder A; Al-Bouri KM; ElTinay M; Badawi HA; Al-Othman AA; Tayara BK; Al-Faraidy MH; Amin AH
    Arch Osteoporos; 2015; 10():37. PubMed ID: 26494131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Moriwaki K; Noto S
    Osteoporos Int; 2017 Feb; 28(2):621-632. PubMed ID: 27699441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Socioeconomic burden of hip fractures in Germany].
    Weyler EJ; Gandjour A
    Gesundheitswesen; 2007 Nov; 69(11):601-6. PubMed ID: 18080931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secular trends in incidence and recurrence rates of hip fracture: a nationwide population-based study.
    Chen FP; Shyu YC; Fu TS; Sun CC; Chao AS; Tsai TL; Huang TS
    Osteoporos Int; 2017 Mar; 28(3):811-818. PubMed ID: 27832325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospitalisations for fracture and associated costs between 2000 and 2009 in Ireland: a trend analysis.
    McGowan B; Casey MC; Silke C; Whelan B; Bennett K
    Osteoporos Int; 2013 Mar; 24(3):849-57. PubMed ID: 22638713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methodology for estimating current and future burden of osteoporosis in state populations: application to Florida in 2000 through 2025.
    Burge RT; King AB; Balda E; Worley D
    Value Health; 2003; 6(5):574-83. PubMed ID: 14627064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.
    Si L; Winzenberg TM; Jiang Q; Palmer AJ
    Osteoporos Int; 2015 May; 26(5):1477-89. PubMed ID: 25567776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The burden of illness of osteoporosis in Canada.
    Tarride JE; Hopkins RB; Leslie WD; Morin S; Adachi JD; Papaioannou A; Bessette L; Brown JP; Goeree R
    Osteoporos Int; 2012 Nov; 23(11):2591-600. PubMed ID: 22398854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom.
    Svedbom A; Hadji P; Hernlund E; Thoren R; McCloskey E; Stad R; Stollenwerk B
    Osteoporos Int; 2019 Sep; 30(9):1745-1754. PubMed ID: 31270592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.
    Mohd-Tahir NA; Li SC
    Osteoporos Int; 2017 Jul; 28(7):2035-2044. PubMed ID: 28314898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.